{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:26:09Z","timestamp":1754108769827},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T00:00:00Z","timestamp":1429747200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s10067-015-2934-x","type":"journal-article","created":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T22:51:46Z","timestamp":1429656706000},"page":"1031-1037","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of tocilizumab on MRI-determined bone oedema in rheumatoid arthritis"],"prefix":"10.1007","volume":"34","author":[{"given":"Nada","family":"Bensaoud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira","family":"Rostom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachid","family":"Bahiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najia","family":"Hajjaj-Hassouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,23]]},"reference":[{"key":"2934_CR1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(08)60453-5","volume":"371","author":"JS Smolen","year":"2008","unstructured":"Smolen JS, Beaulieu A, Rubbert-Roth A, Ramos-Remus C, Rovensky J, Alecock E, Woodworth T, Alten R, for the OPTION Investigators (2008) Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet 371:987\u201397","journal-title":"Lancet"},{"key":"2934_CR2","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/annrheumdis-2013-204762","volume":"73","author":"PG Conaghan","year":"2014","unstructured":"Conaghan PG et al (2014) The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy. Ann Rheum Dis 73:810\u2013816","journal-title":"Ann Rheum Dis"},{"key":"2934_CR3","doi-asserted-by":"crossref","unstructured":"Colebatch AN, et al (2013) EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis 1\u201311","DOI":"10.1136\/annrheumdis-2012-203158"},{"key":"2934_CR4","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2008.092866","volume":"8","author":"N Nishimoto","year":"2009","unstructured":"Nishimoto N, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Azuma J (2009) Long-term safety and efficacy of tocilizumab, an anti IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study. Ann Rheum Dis 8:1580\u20131584","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"2934_CR5","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00296-008-0595-7","volume":"28","author":"FE Abourazzak","year":"2008","unstructured":"Abourazzak FE, Benbouazza K, Amine B, Bahiri R, Lazrak N, Bzami F, Jroundi I, Abouqal R, Guillemin F, Hajjaj-Hassouni N (2008) Psychometric evaluation of a Moroccan version of health assessment questionnaire for use in Moroccan patients with rheumatoid arthritis. Rheumatol Int 28(12):1197\u2013203. doi: 10.1007\/s00296-008-0595-7","journal-title":"Rheumatol Int"},{"issue":"Suppl 1","key":"2934_CR6","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1136\/ard.2004.031773","volume":"64","author":"M Ostergaard","year":"2005","unstructured":"Ostergaard M, Edmonds J, McQueen F, Peterfy C, Lassere M, Ejbjerg B et al (2005) An introduction to the EULAR-OMERACT rheumatoid arthritis MRI reference image atlas. Ann Rheum Dis 64(Suppl 1):i3\u20137","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2934_CR7","first-page":"394","volume":"35","author":"MP Lisbona","year":"2008","unstructured":"Lisbona MP, Maymo J, Perich J, Almirall M, Perez-Garcia C, Carbonell J (2008) Etanercept reduces synovitis as measured by magnetic resonance imaging in patients with active rheumatoid arthritis after only 6 weeks. J Rheumatol 35(3):394\u20137","journal-title":"J Rheumatol"},{"issue":"1","key":"2934_CR8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.12659\/PJR.883768","volume":"78","author":"I Sudo\u0142-Szopi\u0144ska","year":"2013","unstructured":"Sudo\u0142-Szopi\u0144ska I et al (2013) Significance of bone marrow edema in pathogenesis of rheumatoid arthritis. Pol J Radiol 78(1):57\u201363","journal-title":"Pol J Radiol"},{"issue":"12","key":"2934_CR9","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1136\/ard.2010.149377","volume":"70","author":"F Gandjbakhch","year":"2011","unstructured":"Gandjbakhch F, Foltz V, Mallet A, Bourgeois P, Fautrel B (2011) Bone marrow oedema predicts structural progression in a 1-year follow-up of 85 patients with RA in remission or with low disease activity with low-field MRI. Ann Rheum Dis 70(12):2159\u201362","journal-title":"Ann Rheum Dis."},{"key":"2934_CR10","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/rheumatology\/kel137","volume":"45","author":"K Palosaari","year":"2006","unstructured":"Palosaari K et al (2006) Bone oedema predicts erosive progression on wrist MRI in early RA\u2014a 2-yr observational MRI and NC scintigraphy study. Rheumatology 45:1542\u20131548","journal-title":"Rheumatology"},{"key":"2934_CR11","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1136\/ard.2008.092932","volume":"67","author":"P Emery","year":"2008","unstructured":"Emery P, Keystone E, Tony HP, Cantagrel A, van Vollenhoven R, Sanchez A, Alecock E, Lee J, Kremer J (2008) IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial. Ann Rheum Dis 67:1516\u20131523","journal-title":"Ann Rheum Dis"},{"key":"2934_CR12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3109\/s10165-009-0172-2","volume":"19","author":"T Suzuki","year":"2009","unstructured":"Suzuki T, Ito S, Handa S, Kose K, Okamoto Y, Minami M, Hayashi T, Goto D, Matsumoto I, Sumida T (2009) A new low-field extremity magnetic resonance imaging and proposed compact MRI score: evaluation of anti-tumor necrosis factor biologics on rheumatoid arthritis. Mod Rheumatol 19:358\u2013365","journal-title":"Mod Rheumatol"},{"key":"2934_CR13","doi-asserted-by":"crossref","unstructured":"McQueen FM (2012) Bone marrow edema and osteitis in rheumatoid arthritis: the imaging perspective. Arthritis Res Ther 14(5):224. doi: 10.1186\/ar4035","DOI":"10.1186\/ar4035"},{"issue":"Suppl 2","key":"2934_CR14","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar1916","volume":"8","author":"T Kishimoto","year":"2006","unstructured":"Kishimoto T (2006) Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res Ther 8(Suppl 2):S2","journal-title":"Arthritis Res. Ther."},{"key":"2934_CR15","doi-asserted-by":"crossref","first-page":"11924","DOI":"10.1073\/pnas.90.24.11924","volume":"90","author":"T Tamura","year":"1993","unstructured":"Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y et al (1993) Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci U S A 90:11924\u201311928","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2934_CR16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00307733","volume":"13","author":"U Sack","year":"1993","unstructured":"Sack U, Kinne RW, Marx T, Heppt P, Bender S, Emmrich F (1993) Interleukin- 6 in synovial fluid is closely associated with chronic synovitis in rheumatoid arthritis. Rheumatol Int 13:45\u201351","journal-title":"Rheumatol Int"},{"key":"2934_CR17","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/ard.52.3.232","volume":"52","author":"R Madhok","year":"1993","unstructured":"Madhok R, Crilly A, Watson J, Capell HA (1993) Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity. Ann Rheum Dis 52:232\u2013234","journal-title":"Ann Rheum Dis"},{"key":"2934_CR18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/08830189809042997","volume":"16","author":"T Hirano","year":"1998","unstructured":"Hirano T (1998) Interleukin 6 and its receptor: ten years later. Int Rev Immunol 16:249\u2013284","journal-title":"Int Rev Immunol"},{"key":"2934_CR19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1517\/14728222.11.5.613","volume":"11","author":"S Rose-John","year":"2007","unstructured":"Rose-John S, Waetzig GH, Scheller J, Grotzinger J, Seegert D (2007) The IL-6\/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Targets 11:613\u2013624","journal-title":"Expert Opin Ther Targets"},{"key":"2934_CR20","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1002\/art.22033","volume":"54","author":"RN Maini","year":"2006","unstructured":"Maini RN, Taylor PC, Szechinski J, Pavelka K, Broll J, Balint G et al (2006) Doubleblind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate. Arthritis Rheum 54:2817\u20132829","journal-title":"Arthritis Rheum"},{"issue":"7","key":"2934_CR21","first-page":"1426","volume":"30","author":"N Nishimoto","year":"2003","unstructured":"Nishimoto N, Yoshizaki K, Maeda K, Kuritani T, Deguchi H, Sato B et al (2003) Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I\/II clinical study. J Rheumatol 30(7):1426\u201335","journal-title":"J Rheumatol"},{"key":"2934_CR22","doi-asserted-by":"crossref","unstructured":"Suzuki T, Horikoshi M, Sugihara M, Hirota T, Ogishima H, Umeda N, Kondo Y, Tsuboi H, Hayashi T, Chino Y, Matsumoto I, Sumida T (2012) Therapeutic efficacy of tocilizumab in patients with rheumatoid arthritis refractory to anti-tumor-necrosis-factor inhibitors: 1 year follow-up with low-field extremity MRI. Mod Rheumatol","DOI":"10.1007\/s10165-012-0746-2"},{"issue":"6","key":"2934_CR23","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00256-010-1064-4","volume":"40","author":"T Kamishima","year":"2011","unstructured":"Kamishima T, Tanimura K, Shimizu M, Matsuhashi M, Fukae J, Kon Y, Hagiwara H, Narita A, Aoki Y, Kosaka N, Atsumi T, Shirato H, Terae S (2011) Monitoring anti-interleukin 6 receptor antibody treatment for rheumatoid arthritis by quantitative magnetic resonance imaging of the hand and power Doppler ultrasonography of the finger. Skelet Radiol 40(6):745\u201355","journal-title":"Skelet Radiol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-2934-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-015-2934-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-2934-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T18:33:33Z","timestamp":1566585213000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-015-2934-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,23]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["2934"],"URL":"https:\/\/doi.org\/10.1007\/s10067-015-2934-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,23]]}}}